These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24452068)

  • 41. [A new drug: bupropion].
    Vervaeren J
    J Pharm Belg; 2000; 55(4):85-8. PubMed ID: 10994300
    [No Abstract]   [Full Text] [Related]  

  • 42. Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of bupropion in rat everted gut sacs.
    Arellano C; Philibert C; Vachoux C; Woodley J; Houin G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):50-5. PubMed ID: 16246642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
    Hansard MJ; Jackson MJ; Smith LA; Rose S; Jenner P
    Behav Pharmacol; 2011 Jun; 22(3):269-74. PubMed ID: 21522056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion.
    Kustra R; Corrigan B; Dunn J; Duncan B; Hsyu PH
    J Clin Pharmacol; 1999 Nov; 39(11):1184-8. PubMed ID: 10579150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
    Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
    Drug Metab Dispos; 2014 Nov; 42(11):1971-7. PubMed ID: 25187485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bupropion and bupropion analogs as treatments for CNS disorders.
    Carroll FI; Blough BE; Mascarella SW; Navarro HA; Lukas RJ; Damaj MI
    Adv Pharmacol; 2014; 69():177-216. PubMed ID: 24484978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers.
    Lei HP; Ji W; Lin J; Chen H; Tan ZR; Hu DL; Liu LJ; Zhou HH
    Br J Clin Pharmacol; 2009 Aug; 68(2):201-6. PubMed ID: 19694739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate.
    Mohamed MF; Minocha M; Trueman S; Feng T; Enejosa J; Fisniku O; Othman AA
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):299-306. PubMed ID: 32648334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
    Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
    Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ; Chang TK
    Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjunctive aripiprazole for bupropion-resistant major depression.
    Sokolski KN
    Ann Pharmacother; 2008 Jul; 42(7):1124-9. PubMed ID: 18492784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humans.
    Farid NA; Payne CD; Ernest CS; Li YG; Winters KJ; Salazar DE; Small DS
    J Clin Pharmacol; 2008 Jan; 48(1):53-9. PubMed ID: 18094219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy men.
    Gao LC; Huang X; Tan ZR; Fan L; Zhou HH
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1192-6. PubMed ID: 23047502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereoselective Steady-State Disposition and Bioequivalence of Brand and Generic Bupropion in Adults.
    Kharasch ED; Neiner A; Kraus K; Blood J; Stevens A; Miller JP; Lenze EJ
    Clin Pharmacol Ther; 2020 Nov; 108(5):1036-1048. PubMed ID: 32386065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
    Lerman C; Niaura R; Collins BN; Wileyto P; Audrain-McGovern J; Pinto A; Hawk L; Epstein LH
    Psychol Addict Behav; 2004 Dec; 18(4):362-6. PubMed ID: 15631608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bupropion occupancy of the dopamine transporter is low during clinical treatment.
    Meyer JH; Goulding VS; Wilson AA; Hussey D; Christensen BK; Houle S
    Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-related reduction in bupropion plasma concentrations by ritonavir.
    Park J; Vousden M; Brittain C; McConn DJ; Iavarone L; Ascher J; Sutherland SM; Muir KT
    J Clin Pharmacol; 2010 Oct; 50(10):1180-7. PubMed ID: 20484617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonresponse to high-dose bupropion for depression in a patient carrying
    Stäuble CK; Lampert ML; Mikoteit T; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE
    Pharmacogenomics; 2020 Nov; 21(16):1145-1150. PubMed ID: 33124517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Genetic Polymorphisms of CYP2B6 on the Pharmacokinetics of Bupropion and Hydroxybupropion in Healthy Chinese Subjects.
    Ma H; Zhang W; Yang X; Zhang Y; Wei S; Zhang H; Ma Y; Dang H
    Med Sci Monit; 2018 Apr; 24():2158-2163. PubMed ID: 29637923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quetiapine and norquetiapine serum concentrations and clinical effects in depressed patients under augmentation therapy with quetiapine.
    Ostad Haji E; Wagner S; Fric M; Laux G; Pittermann P; Röschke J; Hiemke C
    Ther Drug Monit; 2013 Aug; 35(4):539-45. PubMed ID: 23739636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.